Andrew Bomback

Director of Clinical Research, Division of Nephrology · New York Presbyterian Hospital

Credentials: · · · · ·

History

Diagnostic Utility of Exome Sequencing for Kidney Disease
New England Journal of Medicine · 2019 · 615 citations
The incidence and implications of aldosterone breakthrough
Nature Clinical Practice Nephrology · 2007 · First of 2 authors · Corresponding · 352 citations
Eculizumab for dense deposit disease and C3 glomerulonephritis
Clinical Journal of the American Society of Nephrology · 2012 · First of 12 authors · Corresponding · 286 citations

The Columbia PCC for CureGN: The Cure Glomerulonephropathy Network
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $3.9M · Columbia University Health Sciences
2013–2029
The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.2M · Univ of North Carolina Chapel Hill
2021–2027
Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site
National Institute of Diabetes and Digestive and Kidney Diseases · UH3
PI · $900K · Columbia University Health Sciences
2017–2023
Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis
National Institute on Minority Health and Health Disparities · R01
PI · $2.2M · Columbia University Health Sciences
2014–2021

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2023–2029
Belimumab With Rituximab for Primary Membranous Nephropathy
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2020–2030
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2019–2036
Nephrotic Syndrome Study Network
Site PI · Recruiting
University of Michigan
2010–2030